首页> 外文期刊>The Journal of investigative dermatology. >Detection of melanoma micrometastases in the sentinel lymph node and in nonsentinel nodes by tyrosinase polymerase chain reaction.
【24h】

Detection of melanoma micrometastases in the sentinel lymph node and in nonsentinel nodes by tyrosinase polymerase chain reaction.

机译:通过酪氨酸酶聚合酶链反应检测前哨淋巴结和非前哨淋巴瘤中的黑色素瘤微转移。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

The aim of our study was to investigate the metastatic pathways of melanoma cells in sentinel and other regional lymph nodes. The term "sentinel lymph node" means that the first lymph node of the draining site of a primary tumor is never bypassed in malignant melanoma. In this case lymph node dissection would be necessary only when melanoma cells are detected in the sentinel node. Tyrosinase reverse transcriptase-polymerase chain reaction was applied to search for metastatic melanoma in the sentinel lymph node and in further lymph nodes of a complete lymph node basin in patients who underwent lymph node dissection. In 24 patients with malignant melanoma the draining site of the tumor was marked by lymphoscintigraphy and by intraoperative injection of patent blue V in the area around the primary tumor. The lymph nodes of the affected basin were excised and prepared for histopathologic, immunohistochemical, and molecular biologic examinations. Regarding the sentinel lymph node, 10 of 24 patients showed morphologic evidence for metastases, three additional patients showed only tyrosinase transcripts. In 11 of these 13 cases we found one or more nonsentinel lymph nodes with morphologically detectable melanoma cells and/or tyrosinase mRNA. Interestingly, in seven of 24 patients a positive tyrosinase reverse transcriptase-polymerase chain reaction was received in nonsentinel lymph nodes, whereas the sentinel lymph node was negative, not only for all histologic examinations but also by tyrosinase reverse transcriptase-polymerase chain reaction. In five of seven patients of the latter group, gp100 reverse transcriptase-polymerase chain reaction was carried out, showing also gp100 mRNA in nonsentinel lymph nodes only. Our data indicate that the concept of the sentinel lymph node may miss micrometastases. Whether such micrometastases cause a recurrence or a metastasis of malignant melanoma, or can be destroyed by the immune system, remains to be clarified.
机译:我们研究的目的是研究前哨和其他区域淋巴结中黑色素瘤细胞的转移途径。术语“前哨淋巴结”是指在恶性黑色素瘤中从不绕过原发肿瘤引流部位的第一淋巴结。在这种情况下,仅当在前哨淋巴结中检测到黑色素瘤细胞时才需要进行淋巴结清扫术。酪氨酸酶逆转录酶-聚合酶链反应用于寻找淋巴结清扫患者前哨淋巴结及完整淋巴结盆中进一步淋巴结的转移性黑色素瘤。在24例恶性黑色素瘤患者中,肿瘤的引流部位通过淋巴造影和术中在原发肿瘤周围区域注射漆蓝V标记。切除患盆的淋巴结,并准备进行组织病理学,免疫组织化学和分子生物学检查。关于前哨淋巴结,24例患者中有10例显示了转移的形态学证据,另外3例患者仅显示了酪氨酸酶转录本。在这13例病例中的11例中,我们发现了一个或多个具有形态学上可检测到的黑色素瘤细胞和/或酪氨酸酶mRNA的非前哨淋巴结。有趣的是,在24位患者中有7位在非前哨淋巴结中收到了酪氨酸酶逆转录酶-聚合酶链反应阳性,而前哨淋巴结阴性,不仅在所有组织学检查中,而且酪氨酸酶逆转录酶-聚合酶链反应均阴性。后一组的七名患者中有五名进行了gp100逆转录酶-聚合酶链反应,仅在非前哨淋巴结中也显示了gp100 mRNA。我们的数据表明前哨淋巴结的概念可能会错过微转移。此类微转移是否会导致恶性黑色素瘤复发或转移,或是否可以被免疫系统破坏,尚待阐明。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号